טוען...
The 12/15Lipoxygenase as an emerging therapeutic target for Alzheimer's disease
Alzheimer's disease (AD) is a chronic neurodegenerative condition characterized by progressive memory. Mutations in genes involved in the production of amyloid-β (Aβ) are linked to the early-onset variant of AD. However, the most common form, sporadic AD, is considered the result of an interact...
שמור ב:
| הוצא לאור ב: | Trends Pharmacol Sci |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355395/ https://ncbi.nlm.nih.gov/pubmed/25708815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2015.01.005 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|